| Literature DB >> 25754935 |
Eriko Maeda1, Koichi Murakami, Nobuyuki Sera, Kenitiro Ito, Shuji Fujimoto.
Abstract
Escherichia albertii occasionally causes food-borne outbreaks of gastroenteritis in humans; however, little is known about the vehicle of transmission. To screen retail chicken products for the presence of E. albertii, 104 retail chicken products were investigated. Portions of enrichment cultures that were PCR-positive for E. albertii (n=3) were sub-cultured on agar medium. Only 2 strains obtained from 2 chicken giblet samples were identified as E. albertii by multi locus sequence typing. Antimicrobial susceptibility testing showed that 1 strain was resistant to streptomycin and sulfisoxazole. Both strains harbored the virulence genes cdt and eae. This study is the first description of E. albertii isolation from retail food, suggesting that chicken products are a potential vehicle of E. albertii transmission.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25754935 PMCID: PMC4527513 DOI: 10.1292/jvms.14-0640
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Fig. 1.Phylogenetic tree showing nucleotide sequence clusters of the tested Escherichia albertii strains obtained using multi-locus sequence typing. ST383, ST413, ST95 and ST2819 were included as outgroups. Reference sequences were tested in a previous study [9]. Shigella boydii serotype 13 ATCC 12032 has been reclassified into the Escherichia albertii lineage. The scale bar indicates the number of nucleotide substitutions per site.
Features of Escherichia albertii isolates in this study and in previous studies
| Origins | Number | Virulence-related genesa) | Antimicrobial resistance | References | ||||
|---|---|---|---|---|---|---|---|---|
| This study | ||||||||
| ID 3428 | Chicken giblet | +b) | + | –c) | Susceptible to all antimicrobials tested | This study | ||
| ID 3483 | Chicken giblet | + | + | – | Streptomycin and sulfisoxazole | This study | ||
| Other studies | ||||||||
| Birds | 29 | 100% | 100% | NT | NTd) | [ | ||
| Birds | 9 | 100%e) | 100% | NT | NT | [ | ||
| Birds | 11 | 100%e) | 100% | 9.1% | NT | [ | ||
| Feline | 1 | 100%e) | 0% | 0% | NT | [ | ||
| Swine | 1 | 100% | 100%f) | NT | NT | [ | ||
| Humans | 4 | NT | NT | NT | Ampicillin (0%), chloramphenicol (0%), kanamycin (0%) and tetracycline (100%)g) | [ | ||
| Humans | 48 | 100% | 85% | 4.2% | NT | [ | ||
| Humans | 14 | 100%e) | 100% | 7.1% | NT | [ | ||
| Humans | 21 | NT | NT | NT | Ampicillin (14%), chloramphenicol (62%), ciprofloxacin (0%), kanamycin (0%), streptomycin (76%), gentamicin (0%), tetracycline (100%) and cefixime (0%)h) | [ | ||
| Humans | 1 | 100%e) | 100% | 100% | NT | [ | ||
| Environmental water | 18 | 0% | 83% | 0% | NT | [ | ||
| Uncertain | 3 | NT | NT | NT | Ampicillin (0%), chloramphenicol (0%), gentamicin (0%) and tetracycline (100%)i) | [ | ||
a) eae: Intimin gene, cdt: Cytolethal distending toxin gene, stx2f: Shiga toxin 2f gene. b) +: Detected. c) –: Not detected. d) NT: Not tested. e) Only eae-positive isolates were used in this study. f) Only cdt-positive isolates were used in this study. g) Did not test with ciprofloxacin, nalidixic acid, streptomycin, sulfisoxazole, gentamicin or cefixime. h) Did not test with nalidixic acid or sulfisoxazole. i) Did not test with ciprofloxacin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole or cefixime.